Laurel Wealth Advisors (California)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
$3.51M Buy
21,711
+164
+0.8% +$26.5K 0.35% 67
2022
Q3
$2.89M Buy
21,547
+284
+1% +$38.1K 0.31% 79
2022
Q2
$3.26M Buy
21,263
+370
+2% +$56.7K 0.33% 76
2022
Q1
$3.39M Sell
20,893
-940
-4% -$152K 0.28% 85
2021
Q4
$2.96M Buy
21,833
+4,692
+27% +$635K 0.23% 104
2021
Q3
$1.85M Sell
17,141
-289
-2% -$31.2K 0.34% 59
2021
Q2
$1.96M Sell
17,430
-660
-4% -$74.3K 0.25% 97
2021
Q1
$1.96M Sell
18,090
-169
-0.9% -$18.3K 0.3% 83
2020
Q4
$1.96M Buy
18,259
+97
+0.5% +$10.4K 0.29% 85
2020
Q3
$1.59M Sell
18,162
-22
-0.1% -$1.93K 0.26% 90
2020
Q2
$1.79M Buy
18,184
+1,220
+7% +$120K 0.33% 76
2020
Q1
$1.29M Sell
16,964
-2,117
-11% -$161K 0.3% 86
2019
Q4
$1.69M Sell
19,081
-4,826
-20% -$427K 0.28% 92
2019
Q3
$1.81M Buy
23,907
+4,190
+21% +$317K 0.31% 80
2019
Q2
$1.43M Buy
19,717
+1,536
+8% +$112K 0.31% 81
2019
Q1
$1.47M Buy
18,181
+2,096
+13% +$169K 0.36% 72
2018
Q4
$1.48M Sell
16,085
-890
-5% -$82K 0.44% 61
2018
Q3
$1.61M Buy
16,975
+1,535
+10% +$145K 0.39% 63
2018
Q2
$1.43M Sell
15,440
-82
-0.5% -$7.6K 0.38% 74
2018
Q1
$1.47M Sell
15,522
-1,564
-9% -$148K 0.46% 58
2017
Q4
$1.65M Buy
17,086
+1,700
+11% +$164K 0.48% 56
2017
Q3
$1.37M Sell
15,386
-136
-0.9% -$12.1K 0.46% 65
2017
Q2
$1.13M Buy
15,522
+1,679
+12% +$122K 0.4% 75
2017
Q1
$902K Sell
13,843
-88
-0.6% -$5.73K 0.35% 81
2016
Q4
$872K Sell
13,931
-428
-3% -$26.8K 0.39% 72
2016
Q3
$906K Sell
14,359
-573
-4% -$36.2K 0.43% 65
2016
Q2
$924K Buy
14,932
+156
+1% +$9.65K 0.44% 63
2016
Q1
$844K Buy
14,776
+62
+0.4% +$3.54K 0.42% 66
2015
Q4
$872K Buy
+14,714
New +$872K 0.45% 64